Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3065 |
|
Actual shortage: | 232 (8%) | |
Anticipated shortage: | 15 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2809 (92%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (12%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Avoided shortage | 2017-03-11 | 2017-10-05 | 651 |
APO-EZETIMIBE | 10MG | TABLET | Resolved | 2017-03-11 | 2017-04-25 | 655 |
APO-FOSINOPRIL | 10MG | TABLET | Resolved | 2017-03-11 | 2017-04-10 | 658 |
APO-GABAPENTIN | 300MG | CAPSULE | Resolved | 2017-03-11 | 2017-07-13 | 661 |
APO-LAMIVUDINE | 150MG | TABLET | Resolved | 2017-03-11 | 2017-05-16 | 664 |
APO-LEFLUNOMIDE | 10MG | TABLET | Resolved | 2017-03-11 | 2017-05-23 | 667 |
APO-LEVOFLOXACIN | 750MG | TABLET | Resolved | 2017-03-11 | 2017-07-13 | 670 |
APO-OMEPRAZOLE | 20MG | CAPSULE (DELAYED RELEASE) | Resolved | 2017-03-12 | 2017-04-04 | 674 |
APO-OLANZAPINE | 15.0MG | TABLET | Resolved | 2017-03-12 | 2017-06-05 | 677 |
APO-PRAMIPEXOLE | 0.5MG | TABLET | Resolved | 2017-03-12 | 2017-05-31 | 680 |
APO-PRAMIPEXOLE | 1.0MG | TABLET | Resolved | 2017-03-12 | 2017-06-05 | 683 |
APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Resolved | 2017-03-12 | 2017-04-21 | 686 |
APO-SALVENT TABLETS - 4MG | 4MG | TABLET | Resolved | 2017-03-12 | 2017-05-10 | 689 |
APO-TRAMADOL | 50MG | TABLET | Resolved | 2017-03-12 | 2017-04-17 | 692 |
APO-WARFARIN | 4MG | TABLET | Resolved | 2017-03-12 | 2017-06-08 | 695 |
CEFEPIME FOR INJECTION | 2G | POWDER FOR SOLUTION | Actual shortage | 2017-03-12 | 2017-10-05 | 698 |
APO-ACETAMINOPHEN EXTRA STRENGTH | 500MG | TABLET | Resolved | 2017-03-12 | 2017-10-10 | 701 |
APO-CANDESARTAN | 4MG | TABLET | Resolved | 2017-03-12 | 2018-09-09 | 706 |
APO-ATORVASTATIN | 10MG | TABLET | Resolved | 2017-03-12 | 2017-04-04 | 709 |
APO-ATORVASTATIN | 80MG | TABLET | Resolved | 2017-03-12 | 2017-04-04 | 712 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-RABEPRAZOLE | 10MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-01-04 | 2019-01-04 | 71204 |
APO-METFORMIN ER | 500MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2019-01-04 | 2019-01-04 | 71207 |
ACID REDUCER | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71210 |
APO-LOSARTAN | 100MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71213 |
ACETAMINOPHEN TABLETS USP 500 MG | 500MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71216 |
ACETAMINOPHEN TABLETS USP 325 MG | 325MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71219 |
ACETAMINOPHEN CAPLETS 325 MG | 325MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71222 |
ACETAMINOPHEN CAPLETS 500 MG | 500MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71225 |
NAPROXEN SODIUM TABLETS | 220MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71228 |
APO-IRBESARTAN | 75MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71231 |
APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71234 |
APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71237 |
APO-RIZATRIPTAN RPD | Discontinued | 2019-01-04 | 2019-04-04 | 71334 | ||
APO-BOSENTAN | 62.5MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71339 |
APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71342 |
APO-TELMISARTAN | 40MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71345 |
APO-AMITRIPTYLINE | 10MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71348 |
APO-AMITRIPTYLINE | 25MG | TABLET | Discontinued | 2019-01-04 | 2019-02-13 | 71351 |
APO-AMITRIPTYLINE | 50MG | TABLET | To be discontinued | 2019-01-04 | 2021-06-05 | 71354 |
IBUPROFEN | 200MG | TABLET | Discontinued | 2019-01-07 | 2019-01-07 | 71436 |